BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21329586)

  • 21. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
    Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
    Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
    Zhou YN; Li M
    Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and mutation of β-catenin in non-small cell lung cancer].
    Xu H; Lin D; Wang L; Liu N; Wang E
    Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):409-13. PubMed ID: 21244793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of endostatin and its relationship with the clinical pathophysiological characteristics in non-small cell lung cancer].
    Liu Y; Zhou Q; Zhang S; Liu L; Li F; Xue Y; Che G
    Zhongguo Fei Ai Za Zhi; 2002 Dec; 5(6):447-50. PubMed ID: 21333228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
    J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
    Lee YC; Wu CT; Chen CS; Chang YL
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histopathological and immunohistochemical evaluation of lymph node metastasis in superficial esophageal cancer--with reference to the expression of E-cadherin and alpha-catenin].
    Tamura S; Shiozaki H; Kadowaki T; Inoue M; Oka H; Matsui S; Mori T
    Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):550-6. PubMed ID: 7565577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between protein kinase CβI(PKC-βI) expression, apoptosis and prognosis in patients with non-small cell lung cancer].
    Cheng X; Zhou Q; Wang Y; Zhang S; Liu G; Cheng N
    Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):404-8. PubMed ID: 21244792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms.
    Hsu HP; Shan YS; Jin YT; Lai MD; Lin PW
    J Surg Oncol; 2010 Apr; 101(5):356-62. PubMed ID: 20119975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
    Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
    Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer].
    Cao L; Yang H; Hu C
    Zhongguo Fei Ai Za Zhi; 2003 Dec; 6(6):484-7. PubMed ID: 21310137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on the relationship between the expression of protein kinase C βII and apoptosis in patients with non-small cell lung cancer].
    Cheng X; Zhou Q; Zhang S; Wang Y; Liu G; Cheng N; Liu L
    Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):22-6. PubMed ID: 21211186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-catenin and E-cadherin tissue "content" as prognostic markers in left-side colorectal cancer.
    Martinez NP; Kanno DT; Pereira JA; Cardinalli IA; Priolli DG
    Cancer Biomark; 2010-2011; 8(3):129-35. PubMed ID: 22012768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.